TFAP

Overview

TFAP is a selective cyclooxygenase-1 ( COX-1 ) inhibitor, with an IC 50 of 0.8 μM.

Application

Products | Products > Disease Areas > Arthritis | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > COX | Products > Signaling Pathways > Endogenous Metabolite

Product Information

• Catalog No.: HY-112731
• CAS No.: 1011244-68-0
• Molecular Formula: C13H10F3N3O
• Molecular Weight: 281.23
• Purity: 99.98%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.58 mg/mL (9.17 mM); Clear solution
• Availability: In-stock

Source

Original product source